Publication Information

{'id': 'https://openalex.org/W1992524487', 'doi': 'https://doi.org/10.1159/000094599', 'title': 'Pharmacokinetics of Two Novel Bicalutamide Formulations in Healthy Male Volunteers', 'display_name': 'Pharmacokinetics of Two Novel Bicalutamide Formulations in Healthy Male Volunteers', 'publication_year': 2006, 'publication_date': '2006-01-01', 'ids': {'openalex': 'https://openalex.org/W1992524487', 'doi': 'https://doi.org/10.1159/000094599', 'mag': '1992524487', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/16847400'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1159/000094599', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S106137443', 'display_name': 'Pharmacology', 'issn_l': '0031-7012', 'issn': ['0031-7012', '1423-0313'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310317820', 'host_organization_name': 'Karger Publishers', 'host_organization_lineage': ['https://openalex.org/P4310317820'], 'host_organization_lineage_names': ['Karger Publishers'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5070927117', 'display_name': 'Mireille Cantarini', 'orcid': 'https://orcid.org/0000-0002-9593-9541'}, 'institutions': [{'id': 'https://openalex.org/I105036370', 'display_name': 'AstraZeneca (United Kingdom)', 'ror': 'https://ror.org/04r9x1a08', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I105036370']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Mireille Cantarini', 'raw_affiliation_strings': ['AstraZeneca, Macclesfield, UK, and'], 'affiliations': [{'raw_affiliation_string': 'AstraZeneca, Macclesfield, UK, and', 'institution_ids': ['https://openalex.org/I105036370']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5037371315', 'display_name': 'Rainard Fuhr', 'orcid': None}, 'institutions': [], 'countries': ['DE'], 'is_corresponding': False, 'raw_author_name': 'Rainard Fuhr', 'raw_affiliation_strings': ['PAREXEL International GmbH, Institute of Clinical Pharmacology, Berlin, Germany'], 'affiliations': [{'raw_affiliation_string': 'PAREXEL International GmbH, Institute of Clinical Pharmacology, Berlin, Germany', 'institution_ids': []}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5058225499', 'display_name': 'Thomas Morris', 'orcid': 'https://orcid.org/0000-0003-4957-5625'}, 'institutions': [{'id': 'https://openalex.org/I105036370', 'display_name': 'AstraZeneca (United Kingdom)', 'ror': 'https://ror.org/04r9x1a08', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I105036370']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Thomas Morris', 'raw_affiliation_strings': ['AstraZeneca, Macclesfield, UK, and'], 'affiliations': [{'raw_affiliation_string': 'AstraZeneca, Macclesfield, UK, and', 'institution_ids': ['https://openalex.org/I105036370']}]}], 'institution_assertions': [], 'countries_distinct_count': 2, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 61}, 'biblio': {'volume': '77', 'issue': '4', 'first_page': '171', 'last_page': '178'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T12547', 'display_name': 'Pharmaceutical studies and practices', 'score': 0.9996, 'subfield': {'id': 'https://openalex.org/subfields/2735', 'display_name': 'Pediatrics, Perinatology and Child Health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T12547', 'display_name': 'Pharmaceutical studies and practices', 'score': 0.9996, 'subfield': {'id': 'https://openalex.org/subfields/2735', 'display_name': 'Pediatrics, Perinatology and Child Health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12229', 'display_name': 'Pharmacological Effects and Toxicity Studies', 'score': 0.9988, 'subfield': {'id': 'https://openalex.org/subfields/2735', 'display_name': 'Pediatrics, Perinatology and Child Health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11146', 'display_name': 'Hormonal and reproductive studies', 'score': 0.9943, 'subfield': {'id': 'https://openalex.org/subfields/2712', 'display_name': 'Endocrinology, Diabetes and Metabolism'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/bicalutamide', 'display_name': 'Bicalutamide', 'score': 0.994848}], 'concepts': [{'id': 'https://openalex.org/C2780962315', 'wikidata': 'https://www.wikidata.org/wiki/Q1988832', 'display_name': 'Bicalutamide', 'level': 5, 'score': 0.994848}, {'id': 'https://openalex.org/C112705442', 'wikidata': 'https://www.wikidata.org/wiki/Q323936', 'display_name': 'Pharmacokinetics', 'level': 2, 'score': 0.5872572}, {'id': 'https://openalex.org/C205679159', 'wikidata': 'https://www.wikidata.org/wiki/Q3375179', 'display_name': 'Transdermal', 'level': 2, 'score': 0.5488154}, {'id': 'https://openalex.org/C181389837', 'wikidata': 'https://www.wikidata.org/wiki/Q461809', 'display_name': 'Bioavailability', 'level': 2, 'score': 0.54662895}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.49357402}, {'id': 'https://openalex.org/C2779322244', 'wikidata': 'https://www.wikidata.org/wiki/Q574820', 'display_name': 'Antiandrogen', 'level': 4, 'score': 0.46694767}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.4662522}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.44726837}, {'id': 'https://openalex.org/C134018914', 'wikidata': 'https://www.wikidata.org/wiki/Q162606', 'display_name': 'Endocrinology', 'level': 1, 'score': 0.39101553}, {'id': 'https://openalex.org/C2777911890', 'wikidata': 'https://www.wikidata.org/wiki/Q62614', 'display_name': 'Androgen', 'level': 3, 'score': 0.34514493}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.33889306}, {'id': 'https://openalex.org/C2780192828', 'wikidata': 'https://www.wikidata.org/wiki/Q181257', 'display_name': 'Prostate cancer', 'level': 3, 'score': 0.24674335}, {'id': 'https://openalex.org/C61367390', 'wikidata': 'https://www.wikidata.org/wiki/Q416601', 'display_name': 'Androgen receptor', 'level': 4, 'score': 0.19784552}, {'id': 'https://openalex.org/C71315377', 'wikidata': 'https://www.wikidata.org/wiki/Q11364', 'display_name': 'Hormone', 'level': 2, 'score': 0.18168917}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.103538424}], 'mesh': [{'descriptor_ui': 'D000726', 'descriptor_name': 'Androgen Antagonists', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': True}, {'descriptor_ui': 'D000813', 'descriptor_name': 'Anilides', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': True}, {'descriptor_ui': 'D000284', 'descriptor_name': 'Administration, Oral', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000368', 'descriptor_name': 'Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000369', 'descriptor_name': 'Aged, 80 and over', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000726', 'descriptor_name': 'Androgen Antagonists', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D000726', 'descriptor_name': 'Androgen Antagonists', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D000726', 'descriptor_name': 'Androgen Antagonists', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000813', 'descriptor_name': 'Anilides', 'qualifier_ui': 'Q000097', 'qualifier_name': 'blood', 'is_major_topic': False}, {'descriptor_ui': 'D000813', 'descriptor_name': 'Anilides', 'qualifier_ui': 'Q000737', 'qualifier_name': 'chemistry', 'is_major_topic': False}, {'descriptor_ui': 'D000813', 'descriptor_name': 'Anilides', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019540', 'descriptor_name': 'Area Under Curve', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001682', 'descriptor_name': 'Biological Availability', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018592', 'descriptor_name': 'Cross-Over Studies', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004305', 'descriptor_name': 'Dose-Response Relationship, Drug', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004655', 'descriptor_name': 'Emulsions', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006207', 'descriptor_name': 'Half-Life', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006261', 'descriptor_name': 'Headache', 'qualifier_ui': 'Q000139', 'qualifier_name': 'chemically induced', 'is_major_topic': False}, {'descriptor_ui': 'D006261', 'descriptor_name': 'Headache', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008875', 'descriptor_name': 'Middle Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009570', 'descriptor_name': 'Nitriles', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013237', 'descriptor_name': 'Stereoisomerism', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014105', 'descriptor_name': 'Tosyl Compounds', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1159/000094599', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S106137443', 'display_name': 'Pharmacology', 'issn_l': '0031-7012', 'issn': ['0031-7012', '1423-0313'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310317820', 'host_organization_name': 'Karger Publishers', 'host_organization_lineage': ['https://openalex.org/P4310317820'], 'host_organization_lineage_names': ['Karger Publishers'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/16847400', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'score': 0.45, 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 7, 'referenced_works': ['https://openalex.org/W2012774668', 'https://openalex.org/W2073336624', 'https://openalex.org/W2087203144', 'https://openalex.org/W2091105657', 'https://openalex.org/W2116428025', 'https://openalex.org/W2155982020', 'https://openalex.org/W2246201987'], 'related_works': ['https://openalex.org/W4229984084', 'https://openalex.org/W3148026613', 'https://openalex.org/W2413023094', 'https://openalex.org/W2165611177', 'https://openalex.org/W2154797455', 'https://openalex.org/W2065112594', 'https://openalex.org/W2033996255', 'https://openalex.org/W2010412515', 'https://openalex.org/W1983251925', 'https://openalex.org/W1978560708'], 'abstract_inverted_index': {'The': [0, 16, 109, 120], 'oral': [1], 'bioavailability': [2], 'of': [3, 7, 29, 59, 70, 83, 86, 106, 113, 123], 'two': [4], 'investigational': [5], 'formulations': [6, 98, 163], 'bicalutamide': [8, 60, 94, 134, 157, 162], 'was': [9, 19, 37, 49, 78], 'compared': [10, 132, 155], 'with': [11, 25, 44, 63, 93, 102, 118, 133, 156], 'the': [12, 35], 'current': [13], 'clinical': [14], 'formulation.': [15], 'first': [17], 'formulation': [18], 'amorphous': [20], 'R-/S-bicalutamide': [21], 'in': [22, 40, 72, 88, 140], 'solid': [23, 42], 'dispersion': [24, 43], 'a': [26, 41, 50, 56, 79, 103], 'polymeric': [27], 'matrix': [28], 'hydroxypropyl': [30], 'methylcellulose': [31], 'phthalate': [32], '(HP55S)': [33], '(R-/S-bicalutamide/HP55S);': [34], 'second': [36], 'R-bicalutamide': [38, 124], 'alone': [39], 'HP55S': [45], '(R-bicalutamide/HP55S).': [46], 'Study': [47, 76], '1': [48], 'two-period,': [51, 80], 'incomplete': [52], 'crossover': [53], 'study': [54, 82], 'comparing': [55], 'single': [57, 64, 84], 'dose': [58], '150': [61, 65, 95, 128, 135, 158], 'mg': [62, 68, 129], 'and': [66, 111, 144, 153], '450': [67], 'doses': [69, 85], 'R-/S-bicalutamide/HP55S': [71, 127, 154], 'healthy': [73, 89], 'male': [74, 90], 'volunteers.': [75, 91], '2': [77], 'dose-escalation': [81], 'R-bicalutamide/HP55S': [87, 114, 152], 'Compared': [92], 'mg,': [96], 'both': [97, 151], 'appeared': [99], 'more': [100], 'bioavailable,': [101], 'faster': [104], 'rate': [105], 'systemic': [107], 'absorption.': [108], 'C<sub>max</sub>': [110], 'AUC': [112], 'increased': [115, 130], 'approximately': [116], 'proportionally': [117], 'dose.': [119], 'inter-subject': [121], 'variability': [122], 'exposure': [125], 'for': [126, 150], '2.19-fold': [131], 'mg.': [136, 159], 'Clinically': [137], 'insignificant': [138], 'increases': [139], 'circulating': [141], 'luteinizing': [142], 'hormone': [143], 'testosterone': [145], 'plasma': [146], 'concentrations': [147], 'were': [148, 164], 'observed': [149], 'Both': [160], 'new': [161], 'well': [165], 'tolerated.': [166]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W1992524487', 'counts_by_year': [], 'updated_date': '2024-12-08T21:15:36.153349', 'created_date': '2016-06-24'}